Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Aug;30(2):270–273. doi: 10.1128/aac.30.2.270

Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.

M E Gombert, T M Aulicino, L duBouchet, G E Silverman, W M Sheinbaum
PMCID: PMC180533  PMID: 3532945

Abstract

A mouse model of cerebral nocardiosis was used to determine relative antibiotic efficacy by reducing bacterial colony counts per gram of brain tissue. The antimicrobial agents employed were demonstrated in vitro to be inhibitory to most strains of Nocardia asteroides at very low concentrations. The agents used in this study were imipenem-cilastatin, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antibiotics were administered every 4 h for 72 h before animal sacrifice. Bacterial colony counts were assayed at various time points before the completion of therapy. Imipenem-cilastatin and amikacin were the most effective agents tested. Trimethoprim-sulfamethoxazole was less effective than imipenem and amikacin but more effective than minocycline. Minocycline did not eradicate intracerebral organisms and was similar to saline (control) in its effects.

Full text

PDF
270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Gold O., Finland M. Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice. J Lab Clin Med. 1973 May;81(5):787–793. [PubMed] [Google Scholar]
  2. Bach M. C., Monaco A. P., Finland M. Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. JAMA. 1973 Jun 4;224(10):1378–1381. doi: 10.1001/jama.224.10.1378. [DOI] [PubMed] [Google Scholar]
  3. Beaman B. L., Burnside J., Edwards B., Causey W. Nocardial infections in the United States, 1972-1974. J Infect Dis. 1976 Sep;134(3):286–289. doi: 10.1093/infdis/134.3.286. [DOI] [PubMed] [Google Scholar]
  4. Beaman B. L., Gershwin M. E., Ahmed A., Scates S. M., Deem R. Response of CBA/N x DBA2/F1 mice to Nocardia asteroides. Infect Immun. 1982 Jan;35(1):111–116. doi: 10.1128/iai.35.1.111-116.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beaman B. L., Maslan S. Virulence of Nocardia asteroides during its growth cycle. Infect Immun. 1978 Apr;20(1):290–295. doi: 10.1128/iai.20.1.290-295.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cockerill F. R., 3rd, Edson R. S., Roberts G. D., Waldorf J. C. Trimethoprim/sulfamethoxazole-resistant Nocardia asteroides causing multiple hepatic abscesses. Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspiration. Am J Med. 1984 Sep;77(3):558–560. doi: 10.1016/0002-9343(84)90121-9. [DOI] [PubMed] [Google Scholar]
  7. Curry W. A. Human nocardiosis. A clinical review with selected case reports. Arch Intern Med. 1980 Jun;140(6):818–826. doi: 10.1001/archinte.140.6.818. [DOI] [PubMed] [Google Scholar]
  8. Dalovisio J. R., Pankey G. A. In vitro susceptibility of Nocardia asteroides to amikacin. Antimicrob Agents Chemother. 1978 Jan;13(1):128–129. doi: 10.1128/aac.13.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Geiseler P. J., Andersen B. R. Results of therapy in systemic nocardiosis. Am J Med Sci. 1979 Nov-Dec;278(3):188–194. doi: 10.1097/00000441-197911000-00001. [DOI] [PubMed] [Google Scholar]
  10. Gombert M. E., Aulicino T. M. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983 Nov;24(5):810–811. doi: 10.1128/aac.24.5.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gombert M. E. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Jun;21(6):1011–1012. doi: 10.1128/aac.21.6.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. KRUEGER E. G., NORSA L., KENNEY M., PRICE P. A. Nocardiosis of the central nervous system. J Neurosurg. 1954 May;11(3):226–233. doi: 10.3171/jns.1954.11.3.0226. [DOI] [PubMed] [Google Scholar]
  13. Kim K. S., Anthony B. F. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis. Chemotherapy. 1983;29(6):428–435. doi: 10.1159/000238231. [DOI] [PubMed] [Google Scholar]
  14. RUNYON E. H. Nocardia asteroides; studies of its pathogenicity and drug sensitivities. J Lab Clin Med. 1951 May;37(5):713–720. [PubMed] [Google Scholar]
  15. Rosett W., Hodges G. R. Recent experiences with nocardial infections. Am J Med Sci. 1978 Nov-Dec;276(3):279–285. doi: 10.1097/00000441-197811000-00004. [DOI] [PubMed] [Google Scholar]
  16. Simpson G. L., Stinson E. B., Egger M. J., Remington J. S. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis. 1981 May-Jun;3(3):492–507. doi: 10.1093/clinids/3.3.492. [DOI] [PubMed] [Google Scholar]
  17. Smego R. A., Jr, Moeller M. B., Gallis H. A. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med. 1983 Apr;143(4):711–718. [PubMed] [Google Scholar]
  18. Wallace R. J., Jr, Septimus E. J., Musher D. M., Berger M. B., Martin R. R. Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide. J Infect Dis. 1979 Aug;140(2):244–248. doi: 10.1093/infdis/140.2.244. [DOI] [PubMed] [Google Scholar]
  19. Wallace R. J., Jr, Septimus E. J., Williams T. W., Jr, Conklin R. H., Satterwhite T. K., Bushby M. B., Hollowell D. C. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982 Mar-Apr;4(2):315–325. doi: 10.1093/clinids/4.2.315. [DOI] [PubMed] [Google Scholar]
  20. Wren M. V., Savage A. M., Alford R. H. Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med. 1979 Feb;139(2):249–250. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES